Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects
Clinical trial NCT01210352 · COMPLETED
Trial details
- NCT number
- NCT01210352
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-13
- Primary completion
- 2017-10-06
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.